Dr Sumitro Harjanto

Dr Sumitro Harjanto is a Consultant with the Department of Endocrinology in Changi General Hospital (CGH). He completed his undergraduate studies in Computational Biology at the National University of Singapore (NUS) in 2011, and subsequently obtained his medical degree from the Duke-NUS Graduate Medical School in 2015. In 2018, Dr Harjanto was conferred Membership of the Royal Colleges of Physicians (MCRP) from the United Kingdom. He underwent further training under SingHealth and attained his specialist accreditation in Endocrinology in 2022.

Dr Harjanto has a keen interest in translating technological advances to enhance healthcare and outcomes for patients.

• Specialist Accreditation (Endocrinology), Singapore, 2022
• MRCP(UK), 2018
• MD, 2015

• Diabetes Technology
• Medical Bioinformatics
• Machine Learning and Artificial intelligence 

• Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension Using Urine Mass Spectrometry (ADURINE) - https://clinicaltrials.gov/study/NCT06938633

• Tee, L. Y., Harjanto, S., & Rosario, B. H. (2021). COVID-19 complicated by Hashimoto's thyroiditis. Singapore medical journal, 62(5), 265.
• Harjanto, S., Ng, L. F., & Tong, J. C. (2014). Clustering HLA class I superfamilies using structural interaction patterns. PloS one, 9(1), e86655.
• Harjanto, S., Na, M. X., Hao, Y., Ng, Y. Y., Doctor, N., Goh, E. S., Leong, B. S., Gan, H. N., Chia, M. Y., Tham, L. P., Cheah, S. O., Shahidah, N., Ong, M. E., & PAROS study group (2016). A before-after interventional trial of dispatcher-assisted cardio-pulmonary resuscitation for out-of-hospital cardiac arrests in Singapore. Resuscitation, 102, 85–93.
• Kam, Y. W., Lum, F. M., Teo, T. H., Lee, W. W., Simarmata, D., Harjanto, S., Chua, C. L., Chan, Y. F., Wee, J. K., Chow, A., Lin, R. T., Leo, Y. S., Le Grand, R., Sam, I. C., Tong, J. C., Roques, P., Wiesmüller, K. H., Rénia, L., Rötzschke, O., & Ng, L. F. (2012). Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO molecular medicine, 4(4), 330–343.
• Kam, Y. W., Lee, W. W., Simarmata, D., Harjanto, S., Teng, T. S., Tolou, H., Chow, A., Lin, R. T., Leo, Y. S., Rénia, L., & Ng, L. F. (2012). Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development. Journal of virology, 86(23), 13005–13015.
• Chong, S. L., Harjanto, S., Testoni, D., Ng, Z. M., Low, C. Y., Lee, K. P., & Lee, J. H. (2015). Early Hyperglycemia in Pediatric Traumatic Brain Injury Predicts for Mortality, Prolonged Duration of Mechanical Ventilation, and Intensive Care Stay. International journal of endocrinology, 2015, 719476.